ALI MURAT KAHVECI; VEYSEL TAHAN. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies . Turkish Journal of Gastroenterology, [S. l.], v. 27, n. 1, p. 89–90, 2019. Disponível em: https://tjg.avesjournals.com/index.php/tjg/article/view/3228. Acesso em: 16 jul. 2025.